pharmaphorum10 年
Inhaled insulin recommended by FDA committee
An FDA committee has given an overwhelming recommendation to new inhaled insulin treatment Afrezza. MannKind Corporation has spent years and many millions of dollars in developing the novel ...
pharmaphorum7 年
One Drop and MannKind team for inhalable insulin trial
Diabetes management platform developer One Drop is to feature in a new trial investigating MannKind’s inhalable insulin, Afrezza. Named the A-ONE study, the trial will couple the use of One Drop ...
来自MSN5 个月
Doctors announce new way to treat diabetes with one simple technique
The clinical trial used a product called Afrezza, the only inhaled insulin currently available, made by MannKind Corporation which received FDA approval in 2014. A total of 141 adults were ...
Business Insider India8 年
The incredible history of insulin, a drug that was discovered almost a century ago
Over the years, researchers have also tried to bring inhaled insulin onto the market. Most attempts have failed, but one called Afrezza is currently available.
来自MSN7 个月
Mesa doctor says inhaled insulin being considered ‘standard of care’ expands patient access
She has prescribed Afrezza to her patients since it was granted FDA approval and available in the U.S. nearly a decade ago. It’s the only rapid-acting inhaled insulin on the market and can help ...
Medscape4 个月
Insulin Therapy News
Medscape Medical News, June 27, 2024 ADA 2024 Inhaled Insulin Plus Degludec an Option for Type 1 Diabetes Use of premeal Afrezza insulin plus long-acting degludec insulin was non-inferior to ...